# Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma

> **NCT03598218** · NA · COMPLETED · sponsor: **Wei Jiang** · enrollment: 30 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **RADIATION:** Hypofraction radiation
- **RADIATION:** Standard dose IMRT

## Key facts

- **NCT ID:** NCT03598218
- **Lead sponsor:** Wei Jiang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-13
- **Primary completion:** 2020-06-10
- **Final completion:** 2022-04-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03598218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03598218, "Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03598218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*